Year in review: Tuberculosis 2006;Highlights der tuberkulose-literatur 2006

Pneumologie

Volumn 61, Issue 8, 2007, Pages 518-521

  Lange, Christoph ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BCG VACCINE; CAPREOMYCIN; ETHAMBUTOL; ISONIAZID; KANAMYCIN; RIFAMPICIN; STREPTOMYCIN; PROTEOME;

ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS; ARTICLE; DNA FINGERPRINTING; EPIDEMIC; GENETICS; GERMANY; LUNG TUBERCULOSIS;

DISEASE OUTBREAKS; DNA FINGERPRINTING; GERMANY; HUMANS; PROTEOME; TUBERCULOSIS, PULMONARY;

EID: 34648840177     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-980060     Document Type: Review

References (15)

1. Yew WW, Leung CC. Update in tuberculosis 2006. Am J Respir Crit Care Med 2007; 175: 541-546
2. Ferrara G, Losi M, D'Amico R et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006; 367: 1328-1334
3. Lee JY, Choi HJ, Park IN et al. Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J 2006; 28: 24-30
4. Arena SM, Thijsen SF, Leyten EM et al. Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med 2007; 175: 618-627
5. Rangaka MX, Wilkinson KA, Seldon R et al. Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med 2007; 175: 514-520
6. Jafari C, Ernst M, Kalsdorf B et al. Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot. Am J Respir Crit Care Med 2006; 174: 1048-1054
7. Wilkinson KA, Wilkinson RJ, Pathan A et al. Ex vivo characterization of early secretory antigenic target 6-specific T cells at sites of active disease in pleural tuberculosis. Clin Infect Dis 2005; 40: 184-187
8. Agranoff D, Fernandez-Reyes D, Papadopoulos MC et al. Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet 2006; 368: 1012-1021
9. Gandhi NR, Moll A, Sturm AW et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006; 368: 1575-1580
10. Migliori GB, Ortmann J, Girardi E et al. Extensively Drug-resistant Tuberculosis, Italy and Germany. Emerg Infect Dis 2007; 13 (5): 780-82
11. Singh JA, Upshur R, Padayatchi N. XDR-TB in South Africa: No Time for Denial or Complacency. PLoS Med 2007; 4: e50
12. Kapp C. XDR tuberculosis spreads across South Africa. Lancet 2007; 369: 729
13. Moore DA, Evans CA, Gilman RH et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 2006; 355: 1539-1550
14. Arias M, Mello FC, Pavon A et al. Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis. Clin Infect Dis 2007; 44: 674-680
15. Shiferaw G, Woldeamanuel Y, Gebeyehu M et al. Evaluation of Microscopic Observation Drug Susceptibility Assay for Detection of Multidrug-Resistant Mycobacterium tuberculosis. J Clin Microbiol 2007; 45: 1093-1097